Consumer staples companies that make food products, which is basically what both Kraft Heinz and Coca-Cola offer, are dealing ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Healthy snacks can be an important part of a weight loss eating plan. These snacks for weight loss can provide nutrients and help you reach your goal.

Trademark prosecution data reveals how the rival healthcare companies are ensuring exclusivity internationally for their ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...